Expression of pSTAT3 in human colorectal carcinoma: Correlation with clinico-pathological parameters

Journal of B.U.ON.

Volumn 17, Issue 4, 2012, Pages 691-694

  Zizi Sermpetzoglou, Adamantia ^a   Sawaidou, V ^a   Myoteri, D ^a   Rizos, S ^a   Marinis, A ^a  

^a TZANEIO GENERAL HOSPITAL OF PIRAEUS   (Greece)

Author keywords

Colorectal cancer; Immunohistochemistry; Invasion; Prognosis; pSTAT3; Tumorigenesis

Indexed keywords

STAT3 PROTEIN;

ADULT; ARTICLE; CANCER INVASION; CANCER STAGING; CELL NUCLEUS; CLINICAL EVALUATION; COLORECTAL CARCINOMA; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATIONAL STUDY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOREACTIVITY; INVASIVE CARCINOMA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; TUMOR DIFFERENTIATION;

EID: 84872371211     PISSN: 11070625     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Crawford JM, Mand J, Kumar V. The Oral Cavity and the Gastrointestinal Tract. In: Kumar V, Rubins SL (Eds): Basic Pathology (7th Edn). Saunders, Philadelphia and London, 2003, pp 543-590.
2. Bromberg J. Stat proteins and oncogenesis. J Clin Invest 2002; 109: 1139-1142. (Pubitemid 34496590)
3. Darnell JE Jr. STATs and gene regulation. Science 1997; 277: 1630-1635.
4. Sehgal PB. Paradigm shifts in the cell biology of STAT signaling. Semin Cell Dev Biol 2008; 19: 329-340.
5. Zhong Z, Wen Z, Darnell JE Jr. Stat3: a STAT family member activated by tyrosine phosphorylation in response to epidermal growth factor and interleukin-6. Science 1994; 264: 95-98. (Pubitemid 24144493)
6. Dhir R, Ni Z, Lou W, DeMiguel F, Grandis JR, Gao AC. Stat3 activation in prostatic carcinomas. Prostate 2002; 51: 241-246. (Pubitemid 34556374)
7. Hambek M, Baghi M, Strebhardt K et al. STAT3 activation in head and neck squamous cell carcinomas is controlled by the EGFR. Anticancer Res 2004; 24: 3881-3886. (Pubitemid 40468680)
8. Huang M, Page C, Reynolds RK, Lin J. Constitutive activation of stat 3 oncogene product in human ovarian carcinoma cells. Gynecol Oncol 2000; 79: 67-73.
9. Edge S, Byrd O, Compton C, Fritz A, Greene F, Tronti A (Eds): Cancer Staging Manual (7th Edn). Springer, 2010, pp 143-159.
10. Hamilton R, Borman F, Boffetta P et al. Tumors of the colon and rectum. In: Borman F, Carneiro F, Hruban R, Theise N (Eds): World Health Organization Classification of the Tumors of the Digestive System (4th Edn). IARC Press, Lyon, 2010, pp 132-182.
11. Talbot IC, Ritchie S, Leighton M et al. Invasion of veins by carcinoma of rectum: method of detection, histological features and significance. Histopathology 1981; 5: 141-163. (Pubitemid 11039331)
12. Newland RC, Dent OF, Lyttle MN et al. Pathologic determinants of survival associated with colorectal cancer with lymph node metastases. A multivariate analysis of 579 patients. Cancer 1994; 73: 2076-2082. (Pubitemid 24107961)
13. Dogan L, Karaman N, Yilmaz KB, Ozaslan C, Atalay C, Altinok M. Characteristics and risk factors for colorectal recurrence. J BUON 2010; 15: 61-67.
14. Bell SM, Scott N, Cross D et al. Prognostic value of p53 overexpression and c-Ki-ras gene mutations in colorectal cancer. Gastroenterology 1993; 104: 57-64. (Pubitemid 23040006)
15. Darnell JE Jr Kerr IM, Stark GR. Jak-STAT pathways and transcriptional activation in response to IFNs and other extracellular signaling proteins. Science 1994; 264: 1415-1421.
16. Konjevic G, Radenkovic S, Srdic T, Jurisic V, Stamatovic Lj, Milovic M. Association of decreased NK cell activity and IFNγ expression with pSTAT dysregulation in breast cancer patients. J BUON 2011; 16: 219-226.
17. Ihle JN. Cytokine receptor signalling. Nature 1995; 377: 591-594.
18. Pranada AL, Metz S, Herrmann A et al. Real time analysis of STAT3 nucleocytoplasmic shuttling. J Biol Chem 2004; 279: 15114-15123. (Pubitemid 38618906)
19. Ma XT, Wang S, Ye YJ et al. Constitutive activation of Stat3 signaling pathway in human colorectal carcinoma. World J Gastroenterol 2004; 10: 1569-1573. (Pubitemid 38786933)
20. Masuda M, Suzui M, Yasumatu R et al. Constitutive activation of signal transducers and activators of transcription 3 correlates with cyclin D1 overexpression and may provide a novel prognostic marker in head and neck squamous cell carcinoma. Cancer Res 2002; 62: 3351-3355.
21. David D, Rajappan LM, Balachandran K et al. Prognostic significance of STAT3 and phosphorylated STAT3 in human soft tissue tumors - a clinicopathological analysis. J Exp Clin Cancer Res 2011; 30: 56-64.